Taikang Asset Management (HK)’s Core Laboratories CLB Stock Holding History

Taikang Asset Management (HK)’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,823	Closed	-$1.37M	–	72
2018 Q2	$1.37M	Buy	10,823 +2,818	+35%	+$343K	0.16%	34
2018 Q1	$866K	Buy	8,005 +6,120	+325%	+$677K	0.09%	51
2017 Q4	$207K	Buy	+1,885	New	+$188K	0.02%	73

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Taikang Asset Management (HK)'s CLB Position: Q3 2018 in Review

Taikang Asset Management (HK) sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 10,823 shares — an estimated $1.37M sold.

Taikang Asset Management (HK) first reported a position in CLB in Q4 2017 and held it in 3 quarters. The position peaked at $1.37M in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Taikang Asset Management (HK) reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
Taikang Asset Management (HK) sold 10,823 Core Laboratories shares in Q3 2018, an estimated $1.37M.
Taikang Asset Management (HK) first reported a position in Core Laboratories in Q4 2017 and held it in 3 quarters.
Taikang Asset Management (HK)'s Core Laboratories position peaked at $1.37M in Q2 2018.
359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Taikang Asset Management (HK)'s 13F filing for Q3 2018, filed 29 Oct 2018.